BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. by Luqiong Liu (11537092)

“…The values are expressed as the means ± SDs and were analyzed according to the variance of the factorial design. **, *** and ****denote <i>p</i> < 0.01, < 0.001 and < 0.0001, respectively; ns  =  not significant.…”

Y-27632 synergized with BA to alleviate the decrease in the expression of and abnormal localization of ZO-1 and Occludin in LPS-induced Caco2 cells. by Luqiong Liu (11537092)

Summary of the effect of MPDD on SDLP across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “-” (sign... by Mobina Faqani (22783963)

Summary of the effect of MPDD on ART and TIBL across all participants, and also participants categorized by driving styles (“NS” (no significant), “+” (significant increase), and “... by Mobina Faqani (22783963)

Bar graphs showing the means and 95% CI of each retinal layer thickness at each visit. by Jung-Tae Kim (8997767)

Subjects:

Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

BIMAST score vs FIB-4 for predicting significant and advanced fibrosis in the Sicilian cohort. by Roberta Forlano (9499666)

BIMAST score vs FIB-4 for predicting significant and advanced fibrosis in the Royal Free cohort. by Roberta Forlano (9499666)

Mean scores, standard deviations, and significance on key measures and subscales by gender group. by Silas Manning (22693338)

BA attenuated the decrease in the integrity and increase in the permeability of the epithelial barrier injury induced by LPS in Caco2 cell monolayers. by Luqiong Liu (11537092)

Diagnostic performance of the BIMAST score for predicting significant and advanced fibrosis in the derivation cohort (diabetes primary care). by Roberta Forlano (9499666)

Risk Factors related to Frailty in patients with advanced chronic kidney disease. by Rocio Gimena Muñoz (22339634)

Subjects:

Foslevodopa/Foscarbidopa: A Review in Advanced Parkinson’s Disease by Hannah A. Blair (13864794)

“…It is approved for the treatment of motor fluctuations in patients with advanced Parkinson’s disease (PD). Administered via an ambulatory infusion pump, it allows for personalized dosing based on individual needs. …”

Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. by Mohammad Bakhtiari (11838264)

The effect of HA digestion and HA replenishment alone or with CS on barrier function measured by TEER. by Charlotte J. van Ginkel (20790466)

“…In (B) and (C) each point represents a mean ± standard deviation. (B) Hyaluronidase treatment (n = 8) gradually increased TEER, this significantly differed from the untreated group (n = 8) and the PS treated group (n = 8) (p < 0,001). …”

Summary of significant treatment × time effect. by Wensheng Xiao (16557866)

The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

Most significant muscle activation values. by María Benito-de-Pedro (22057468)

Subjects:

Mean values of physical parameters of rock samples. by Dengke Yang (842532)